Louisiana Meth
addiction treatment
1-866-635-1001

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Louisiana
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Mexico
New York
New Hampshire
New Jersey
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
 
Louisiana drug rehab
 

Drug Rehab Centers Services will assist you in finding help for methamphetamine addiction and rehabilitation in Louisiana. Our certified counselors will guide you and your family in this important moment in finding a meth treatment in the state of Louisiana.

Methamphetamine has destroyed several families, relationships and lives in Louisiana. There are still well over 1 million people in the United States who need rehabilitation for methamphetamine addiction.

But there is hope as many with a methamphetamine addiction got their lives back after attending a meth rehab center.

Drug Rehab Services philosophy is to provide honest, caring and knowledgeable advice, support and referrals according to your unique circumstance.
Our mission is to achieve a drug-free world.
Our goal is to help drug addicts and families find a rehab.

Help is just a phone call away!
Call one of our counselor today!
1-866-635-1001
Online consultation

Methamphetamine overview in Louisiana

Methamphetamine abuse is increasing in the state of Louisiana, especially in the north of Louisiana. Drug abuse counselors in some addiction treatment centers in northern part of the state of Louisiana report meth is now the drug of choice in their areas. Many police in northernpart of Louisiana report a raise in domestic violence related to meth abuse. Increasingly, meth is being manufactured in mobile labs, using a simple technique known as the "Nazi method." Meth is also produced by Mexican criminal organizations and transported into the state. In general, meth is distributed by independent Caucasian dealers, producers, and OMGs.

Law enforcement and addiction treatment providers indicate meth abuse is increasing in the state of Louisiana, especially in the northern rural area. In Bossier and Caddo Parishes, both situated in the northwest corner of the state,addiction treatment counselors state that although crack continues to be the main drug of abuse reported by clients upon admission, meth is showing up as the self-described drug of choice.

Methamphetamine is accessible over the counter as Vicks inhaler as a nasal decongestant. Methamphetamine alone can increase blood pressure and cause the heart to beat quickly due to its effects mimicking the sympathetic nervous system, but is not thought to be nearly as addictive or centrally active as the d- isomer of methamphetamine. Meth's usual side effects are muscle tremors and stomach cramps.

 Pharmacology

Methamphetamine is a potent central nervous system stimulant which affects neurochemical mechanisms responsible for controlling heart rate, body temperature, blood pressure, appetite, attention, mood and answers associated with alertness or alarm conditions. The methyl group is responsible for the potentiation of effects as compared to the related compound amphetamine, rendering the drug more lipid soluble and facilitating transport across the blood brain barrier.
Methamphetamine creates the norepinephrine and dopamine transporters to reverse their direction of flow. This inversion leads to a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse, causing risen stimulation of post-synaptic receptors. Methamphetamine also indirectly stops the reuptake of these neurotransmitters, causing them to stay in the synaptic cleft for a prolonged period. Serotonin levels are only weakly affected.  It is a potent neurotoxin, proven to cause dopaminergic degeneration.

The acute effects of the drug closely look alike the physiological and psychological effects of an epinephrine-provoked fight-or-flight response, including increased heart rate and blood pressure, vasoconstriction (constriction of the arterial walls), bronchodilation, and hyperglycemia (increased blood sugar). Meth users experience a raise in focus, increased mental alertness, and the elimination of fatigue, as well as suppression in appetite.

Globally, the manufacture and use of the synthetic narcotics amphetamine, methamphetamine, and MDMA (Ecstasy) remain a serious concern. There are several foreign origins for synthetic drugs and their precursors, including countries in Asia, Europe, and North America. Use patterns are strongly regional, with methamphetamine used in the United States and Asia. Amphetamines and Ecstasy are the drugs of choice in Europe. U.S. law enforcement still act in cooperation with law enforcement authorities worldwide to disrupt foreign sources of the bulk pseudoephedrine and ephedrine that are used to produce methamphetamine consumed in the United States. The Strategy will keep its emphasis on confronting and disrupting the synthetic drug markets through both organizational attack activities targeting important synthetic drug trafficking organizations and chemical control initiatives focused on keeping the essential precursors out of traffickers' hands. In combination, the aggressive application of organizational attack and chemical control programs can disrupt the illegal synthetic narcotic market.

Meth treatment admissions per 100,000 residents (2003): 18

Methamphetamine is currently the fastest growing drug concern in Louisiana. Even though more individuals seek treatment for cocaine or cannabis abuse, the number of individuals seeking treatment for a meth addiction is on the rise: from only 355 in 2000 to a record 1,084 in 2004, or approximately 3.8% of all individuals seeking drug abuse treatment. While most of the meth in circulation in Louisiana is manufactured in Mexico or the south-western United States, local manufacture is also on the rise. During 2004, DEA, state and local authorities seized 123 clandestine laboratories, in comparison to only 15 in 2000.

Update:

The Combat Meth Act, signed by President Bush on March 9, 2006, gives minimum standards for retailers across the nation that sell substances containing ephedrine and pseudoephedrine. The law limits sales to 3.6 grams of the base ingredient (the pure ephedrine or pseudoephedrine) daily and 9 grams monthly, and requires that buyers provide identification and sign a sales log. Also, sellers must keep these substances behind the counter or in a locked case and register on-line with the U.S. Attorney General.

Help is just a phone call away!
Call one of our counselor today!
1-866-635-1001
Online consultation

 

 
  Copyright @2006 Drug rehab services
All rights reserved.